Acarix AS Financials
| ACARIX Stock | SEK 0.30 0.01 3.23% |
Acarix |
Understanding current and past Acarix AS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Acarix AS's financial statements are interrelated, with each one affecting the others. For example, an increase in Acarix AS's assets may result in an increase in income on the income statement.
Please note, the presentation of Acarix AS's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acarix AS's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Acarix AS's management manipulating its earnings.
Acarix AS Stock Summary
Acarix AS competes with Cantargia, BioArctic, Hansa Biopharma, and BioInvent International. Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0009268717 |
| Business Address | World Trade Center, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.acarix.com |
| Phone | 46 1 04 71 58 02 |
| Currency | SEK - Swedish Kronor |
You should never invest in Acarix AS without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Acarix Stock, because this is throwing your money away. Analyzing the key information contained in Acarix AS's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Acarix AS Key Financial Ratios
Acarix AS's financial ratios allow both analysts and investors to convert raw data from Acarix AS's financial statements into concise, actionable information that can be used to evaluate the performance of Acarix AS over time and compare it to other companies across industries.| Return On Equity | -1.46 | |||
| Return On Asset | -0.8 | |||
| Target Price | 0.75 | |||
| Beta | 1.65 |
Acarix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Acarix AS's current stock value. Our valuation model uses many indicators to compare Acarix AS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acarix AS competition to find correlations between indicators driving Acarix AS's intrinsic value. More Info.Acarix AS is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acarix AS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acarix AS's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Acarix AS Systematic Risk
Acarix AS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Acarix AS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Acarix AS correlated with the market. If Beta is less than 0 Acarix AS generally moves in the opposite direction as compared to the market. If Acarix AS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Acarix AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Acarix AS is generally in the same direction as the market. If Beta > 1 Acarix AS moves generally in the same direction as, but more than the movement of the benchmark.
Acarix AS December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Acarix AS help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Acarix AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Acarix AS based on widely used predictive technical indicators. In general, we focus on analyzing Acarix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Acarix AS's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.74 | |||
| Information Ratio | 0.0232 | |||
| Maximum Drawdown | 40.34 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 9.68 |
Complementary Tools for Acarix Stock analysis
When running Acarix AS's price analysis, check to measure Acarix AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acarix AS is operating at the current time. Most of Acarix AS's value examination focuses on studying past and present price action to predict the probability of Acarix AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acarix AS's price. Additionally, you may evaluate how the addition of Acarix AS to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |